Literature DB >> 29043203

Endomyocardial fibrosis.

Paulo Sampaio Gutierrez1, Fernando Peixoto Ferraz de Campos2.   

Abstract

Entities:  

Keywords:  Autopsy; Diagnosis; Endomyocardial Fibrosis

Year:  2017        PMID: 29043203      PMCID: PMC5634427          DOI: 10.4322/acr.2017.024

Source DB:  PubMed          Journal:  Autops Case Rep        ISSN: 2236-1960


× No keyword cloud information.

Figure 1. Gross view of the mid-ventricular transversal section of the heart showing extensive areas of white fibrosis in the endocardium of the left ventricle that has diffusely thickened the lining of the chamber and involved the papillary muscles. Note the presence of trabeculae that extend across the myocardium.

Image courtesy Dr. Paulo Sampaio Gutierrez The specimen shown in the picture (Figure 1) belonged to a 63-year-old female patient who was referred to the Pulmonologist because of a long-standing complaint of cough and dyspnea. She was a hairdresser and had smoked 8 pack years. The work-up, among other examinations, included echocardiogram, cinecoronarioangiography, and cardiac magnetic resonance imaging (MRI), which disclosed the diagnosis of endomyocardial fibrosis. She was submitted to surgical treatment with partial resection of the left ventricle’s endocardium, replacement of the mitral valve by a bioprosthesis, and tricuspid valve repair. Four months later, she was admitted with fever and signs of sepsis, and died soon after. The necropsy and blood culture samples (the results of which were available after death) revealed endocarditis of the mitral prosthesis due to Streptococcus viridans. Endomyocardial fibrosis (EMF)—also called tropical endomyocardial fibrosis—is a restrictive cardiomyopathy of unknown cause. It is characterized by the deposition of fibrous tissue in the endomyocardium, which leads to a restrictive physiology accompanied by a very poor prognosis without a specific management. This results in demise, which is usually due to heart failure, arrhythmias, and thromboembolism. The disease is endemic in Africa, where the first case was described in 1948 (Uganda),1 but also has a high frequency in Asia (India2,3 and China4) and South America (Brazil5 and Colombia6). Grimaldi et al.7 called it a disease of poverty, since it afflicts the rural populations of low-income countries. Genetic, environmental, and socioeconomic factors may explain the persistent particular geographic distribution, as well as the decline of prevalence in other areas that have shown social and economic improvement. EMF presents a bimodal distribution peaking at 10 and 30 years of age. Gender seems to lack any predominance, and varies according to the series and the country of the study. The etiopathogenesis of EMF remains in the field of hypotheses and far from exact knowledge; therefore, it demands systematic research with the aid of current technologies. The seemingly implicated factors, besides ethnicity, poverty, eosinophilia, autoimmunity, and serotonin, are related to: (i) the excessive immune response against certain parasitic infections; (ii) dietary scarcity (malnutrition); (iii) herbal preparations; and (iv) the use of improperly processed or cooked cassava as the primary source of carbohydrate (because of the ingestion of toxic levels of cyanogenic glycoside).8-12 The occurrence of familial cases supports the participation of genetic predisposition.7 Although not yet a consensus, the high prevalence of anti-heart antibodies detected in patients with EMF somehow suggests the involvement of autoimmunity in the pathogenesis.13 Similarly, the usual association of hypereosinophilia with EMF has led some authors to consider this entity as the tropical variant of hypereosinophilic syndrome, which is found in temperate climates with the overproduction of interleukin-5 and fibrotic lesions identical to those seen in EMF.14 Typically, EMF presents an insidious onset, usually associated with fever, pancarditis, and eosinophilia, which are morphologically abnormal. This initial active form also presents dyspnea, itching, and periorbital edema.15 The clinical features of EMF will depend on the predominantly affected cardiac chamber and the duration of disease. Lower limbs edema, ascites, and non-specific gastrointestinal complaints (e.g. nausea, vomiting, and anorexia) are characteristic of the right ventricular and tricuspid valve involvement. However, when the left ventricle is affected, dyspnea, exertional dyspnea, orthopnea, nocturnal paroxysmal dyspnea, and fatigue will predominate. Thromboembolic events, angina-like chest pain, arrhythmias, and syncope, may also take part of the clinical features of EMF involving the left chamber. Growth retardation, testicular atrophy, clinical feminization, finger and toe clubbing, and cachexia are the consequence of low cardiac output in a chronic disease.16 Left ventricular involvement, isolated or in combination with biventricular disease, is most often encountered in the chronic form of the disease, followed by isolated right-side involvement. In the latter, the physical examination shows signs of systemic venous hypertension with multi-visceral congestion, accompanied (or not) by pulmonary hypertension due to pulmonary thromboembolism. Some characteristic signs include central cyanosis, exophthalmos, giant ascites without pedal edema (sometimes accompanied by peritoneal fibrosis), hyperpigmentation of the lips and gums, proptosis, and parotid swelling. Although chest x-ray and electrocardiogram may show several abnormalities, none of them are specific. However, the echocardiogram is the gold standard technique for the diagnosis of the chronic disease.17 Dense endocardial echograms along the mural and valvular endocardium, valvular dysfunction, a restrictive filling pattern with shrinkage of the cavity, the presence of thrombus, and the detection of pericardial effusion are the most typical echocardiographic findings.18 MRI adds precision to the diagnosis, showing hypoperfused fibrotic areas, and confirms the presence of thrombus and calcifications.19 The most prominent pathological characteristics of EMF20 is a massive deposition of granulation tissue and extracellular proteins, mainly collagen type I, but also collagen type III and elastic fibers, at the endocardium of any or both ventricles. This connective tissue surrounds the papillary muscles and covers the walls of the cavities, thickening the walls and causing a stiffness that impairs the expansion of the chamber. The problem is frequently worsened by calcification and/or mural thrombosis. Typically, the boundaries between the thickened endocardium and the myocardium are not clear-cut, and there are tongues of fibrous tissue penetrating the intertrabecular spaces. Apical portions of the cavities (as well as their inlets) are more commonly committed, and the outlets are almost always free. In spite of the relationship with eosinophilia, significant infiltrates by eosinophils are not seen in the majority of cases.
  15 in total

1.  Endomyocardial fibrosis and the tuberous diet.

Authors:  H Davies
Journal:  Int J Cardiol       Date:  1990-10       Impact factor: 4.164

2.  Images in cardiovascular medicine. Visualization of endomyocardial fibrosis by delayed-enhancement magnetic resonance imaging.

Authors:  Ricardo C Cury; Suhny Abbara; Larry J-Diaz Sandoval; Stuart Houser; Thomas J Brady; Igor F Palacios
Journal:  Circulation       Date:  2005-03-08       Impact factor: 29.690

3.  Endomyocardial fibrosis: pathological and molecular findings of surgically resected ventricular endomyocardium.

Authors:  Silvia D'Andretta Iglezias; Luiz Alberto Benvenuti; Fiorella Calabrese; Vera Maria Cury Salemi; Ana Maria Gonçalves Silva; Elisa Carturan; Sergio Almeida de Oliveira; Gaetano Thiene; Thales De Brito
Journal:  Virchows Arch       Date:  2008-09-02       Impact factor: 4.064

4.  Endomyocardial fibrosis in Kerala.

Authors:  D V Nair
Journal:  Indian Heart J       Date:  1971-07

5.  Echocardiography accurately assesses the pathological abnormalities of chronic endomyocardial fibrosis.

Authors:  A O Mocumbi; C Carrilho; P Sarathchandra; M B Ferreira; M Yacoub; M Burke
Journal:  Int J Cardiovasc Imaging       Date:  2010-11-26       Impact factor: 2.357

6.  Effect of protein deficient cassava diet on Cercopithecus aethiops hearts and its possible role in the aetiology and pathogenesis of endomyocardial fibrosis in man.

Authors:  C L Sezi
Journal:  East Afr Med J       Date:  1996-05

7.  Geographical distribution of endomyocardial fibrosis in south Kerala.

Authors:  V R Kutty; S Abraham; C C Kartha
Journal:  Int J Epidemiol       Date:  1996-12       Impact factor: 7.196

8.  Presence of circulating anti-myosin antibodies in endomyocardial fibrosis.

Authors:  Ana Olga Mocumbi; Najma Latif; Magdi H Yacoub
Journal:  PLoS Negl Trop Dis       Date:  2010-04-20

Review 9.  Endomyocardial fibrosis in China.

Authors:  R Yin
Journal:  Chin Med Sci J       Date:  2000-03

Review 10.  Tropical Endomyocardial Fibrosis: Natural History, Challenges, and Perspectives.

Authors:  Antonio Grimaldi; Ana Olga Mocumbi; Juergen Freers; Matthias Lachaud; Mariana Mirabel; Beatriz Ferreira; Kumar Narayanan; David S Celermajer; Daniel Sidi; Xavier Jouven; Eloi Marijon
Journal:  Circulation       Date:  2016-06-14       Impact factor: 29.690

View more
  2 in total

1.  Endomyocardial fibrosis in a non-tropical patient who presented with chest pain mimicking ACS and left ventricular thrombus, case report.

Authors:  Ahmad S Matarneh; Yousef M Ali Hailan; Sabir Abdul Karim; Maryam A Al Kuwari; Wafer A Dabdoob
Journal:  Clin Case Rep       Date:  2022-05-23

2.  One year with autopsy and case reports: an immense educational experience.

Authors:  Ameer Hamza
Journal:  Autops Case Rep       Date:  2018-04-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.